Group One Trading’s Adaptive Biotechnologies ADPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.39K Sell
100
-1,600
-94% -$25.5K ﹤0.01% 7152
2025
Q4
$27.6K Hold
1,700
﹤0.01% 6095
2025
Q3
$25.4K Buy
1,700
+900
+113% +$11K ﹤0.01% 6520
2025
Q2
$9.32K Buy
+800
New +$7.27K ﹤0.01% 6763
2024
Q2
Sell
-4,300
Closed -$13.8K 6629
2024
Q1
$13.8K Sell
4,300
-40,000
-90% -$155K ﹤0.01% 5676
2023
Q4
$217K Buy
44,300
+4,300
+11% +$19.6K ﹤0.01% 3801
2023
Q3
$218K Buy
+40,000
New +$265K ﹤0.01% 3734
2023
Q2
Sell
-15,000
Closed -$132K 7586
2023
Q1
$132K Buy
15,000
+4,800
+47% +$42.3K ﹤0.01% 4039
2022
Q4
$77.9K Buy
+10,200
New +$79.4K ﹤0.01% 4657
2022
Q3
Sell
-1,600
Closed -$13K 7463
2022
Q2
$13K Sell
1,600
-14,800
-90% -$130K ﹤0.01% 6586
2022
Q1
$228K Buy
16,400
+16,300
+16,300% +$256K ﹤0.01% 4657
2021
Q4
$3K Sell
100
-200
-67% -$6.13K ﹤0.01% 7755
2021
Q3
$10K Sell
300
-9,800
-97% -$354K ﹤0.01% 7486
2021
Q2
$413K Buy
10,100
+5,500
+120% +$214K ﹤0.01% 4438
2021
Q1
$185K Buy
4,600
+4,500
+4,500% +$244K ﹤0.01% 5100
2020
Q4
$6K Sell
100
-600
-86% -$30.9K ﹤0.01% 5949
2020
Q3
$34K Sell
700
-8,500
-92% -$357K ﹤0.01% 4866
2020
Q2
$445K Buy
9,200
+7,900
+608% +$288K ﹤0.01% 2737
2020
Q1
$36K Buy
+1,300
New +$36.3K ﹤0.01% 3918
2019
Q4
Sell
-100
Closed -$3K 5054
2019
Q3
$3K Buy
+100
New +$4.08K ﹤0.01% 4844

Other funds holding ADPT

Group One Trading's ADPT Position: Q3 2025 in Review

Group One Trading sold out of Adaptive Biotechnologies (ADPT) in Q3 2025, closing a stake of 887 shares — an estimated $10.8K sold.

Group One Trading first reported a position in ADPT in Q4 2019 and held it in 13 quarters. The position peaked at $296K in Q4 2022. 271 funds tracked by Wall St. Rank hold ADPT as of Q3 2025.

  • Group One Trading reported no remaining Adaptive Biotechnologies position as of Q3 2025 after selling out during the quarter.
  • Group One Trading sold 887 Adaptive Biotechnologies shares in Q3 2025, an estimated $10.8K.
  • Group One Trading first reported a position in Adaptive Biotechnologies in Q4 2019 and held it in 13 quarters.
  • Group One Trading's Adaptive Biotechnologies position peaked at $296K in Q4 2022.
  • 271 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q3 2025.

Based on Group One Trading's 13F filing for Q3 2025, filed 12 Nov 2025.